We don’t just fund the future.
We build it with you.
At ELEVO, we go beyond capital deployment. We are co-founders, ecosystem builders, and innovation translators. We turn world-class science into scalable ventures—rigorously selected, expertly built, and globally relevant.
A €500B+ Global Gap, Ripe for Investment
Each year, billions are poured into deep tech research, but less than 10% of breakthroughs ever reach the market. The bottleneck isn’t invention, it’s translation.
ELEVO is your access point to a massive untapped asset class: frontier technologies with verified scientific merit and rising real, world demand. From AI to longevity, we curate, validate, and co-build ventures that matter.
Our Investment Thesis
We invest where science meets scale:
Breakthrough technologies emerging from top-tier research institutions.
Validated market demand guided by our TIME Matrix.
Strong founding teams, ready to lead scalable ventures.
Structural tailwinds such as regulatory urgency, demographic shifts, and industrial adoption.
Our dual-evaluation system—TIME (Technology Readiness × Importance) and FRL (Founding Readiness Level)—ensures we prioritize only those projects that are both investable and impactful.
WHY ELEVO IS DIFFERENT
Hands-On Model: We Co-Found, Not Just Fund
At ELEVO, we don’t just write checks—we roll up our sleeves. We step in as active co-founders, embedding ourselves into the venture from day one. This involvement ensures that:
Governance structures are built for scale.
Product-market fit is validated early.
Cap tables are clean and aligned.
Strategic milestones are hit with discipline.
This approach drives higher alignment, tighter execution, and more predictable outcomes—key factors for reducing early-stage risk and maximizing long-term upside.
Scientific & Market Expertise: Bridging Lab and Capital
ELEVO is built on a rare combination: deep scientific literacy and commercial rigor. Our team includes former heads of innovation at leading institutions (like IIT), serial entrepreneurs, IP strategists, and capital markets experts.
We understand:
The nuance of evaluating TRL, IP defensibility, and scalability.
The realities of startup formation, investor expectations, and exit dynamics.
This dual fluency allows us to accurately de-risk ventures before they hit the market—and then position them for rapid scaling.
Scalable Platform: A Repeatable Model for Global Impact
ELEVO isn’t a one-off fund—it’s a platform. We partner with leading research institutions worldwide, embedding a repeatable venture-building engine that scales with each partnership.
Our IMPACT framework moves projects from research to startup with standardized diligence, milestones, and playbooks.
Our TIME + FRL evaluation system ensures we select the right opportunities and spin them out only when they’re truly ready.
Our international roadmap includes outposts in top tech transfer ecosystems across Europe and beyond.
Blended Capital Approach: Structured for Resilience
Our financial model is designed to protect downside and accelerate upside. We blend:
Public grants and incentives (e.g., EU, PNRR, national innovation funds).
Non-dilutive capital (for early validation and team formation).
Private equity (through seed and follow-on rounds).
This strategy reduces burn, extends runway, and improves IRR across the portfolio. For investors, it means more leverage, less dilution, and lower risk per euro invested.
The result: a growing pipeline of de-risked, high-quality ventures ready for capital and scale.

Partner with us
We invite venture investors seeking exclusive deep-tech deal flow, corporate partners looking for strategic innovation, and impact-oriented funds aligned with science-based sustainability and societal transformation.
Together, we can build a portfolio of technologies that will define the next decade.